BS ISO 20688-2:2024
$167.15
Biotechnology. Nucleic acid synthesis – Requirements for the production and quality control of synthesized gene fragments, genes, and genomes
Published By | Publication Date | Number of Pages |
BSI | 2024 | 38 |
PDF Catalog
PDF Pages | PDF Title |
---|---|
2 | undefined |
7 | Foreword |
8 | Introduction |
9 | 1 Scope 2 Normative references 3 Terms and definitions |
11 | 4 Requirements for quality management 4.1 General requirements |
12 | 4.2 Control of documents |
13 | 4.3 Quality management system 4.4 Biorisk management and safety control 5 Requirements for resource management 5.1 Facilities and environmental condition 5.2 Equipment and instruments |
14 | 5.3 Raw materials 5.4 Personnel 6 Biosafety and biosecurity requirements 6.1 General 6.2 DNA sequence screening mechanism |
15 | 7 Requirements for quality control in production 7.1 General 7.2 Quality control in synthetic gene fragments production 7.2.1 General 7.2.2 Sequence design |
16 | 7.2.3 Assembly 7.2.4 Purification 7.2.5 Product preservation 7.3 Quality control in synthetic gene production 7.3.1 General 7.3.2 Colony screening 7.3.3 DNA preparation from the host cell |
17 | 7.3.4 Sequence verification 7.3.5 Product preservation 7.4 Quality control in synthetic genome production 7.4.1 General 7.4.2 Assembly 7.4.3 Sequence verification |
18 | 8 Requirements for product quality 8.1 Synthetic gene fragments 8.1.1 General 8.1.2 Yield 8.1.3 Purity 8.1.4 Size 8.1.5 Gene cloning accuracy 8.2 Synthetic genes 8.2.1 General 8.2.2 Yield |
19 | 8.2.3 Purity 8.2.4 Sequence 8.2.5 Integrity 8.2.6 Residual impurities analysis |
20 | 8.2.7 Supercoiled plasmid 8.2.8 Bioburden 8.2.9 Specific quality indicators for synthetic DNA libraries 8.3 Synthetic genome 8.3.1 General 8.3.2 Sequence |
21 | 9 Delivered/synthesized material specifications 9.1 Main information 9.2 Other information |
22 | Annex A (informative) Example equipment and device list and their control requirements |
24 | Annex B (informative) Exemplary quality measurement methods |
26 | Annex C (informative) Electrophoretogram |
30 | Annex D (informative) Sanger sequencing |
31 | Annex E (informative) Massively parallel sequencing |
34 | Annex F (informative) Additional quality control options for synthetic gene fragments |
36 | Annex G (informative) Example ranking of the risk posed by DNA products |
37 | Bibliography |